risks of glp 1 inhibitors what are the expanding role GLP-1 receptor agonists: a narrative review of current evidence and future directions Do The Benefits of GLP-1 – Mapping the effectiveness and risks

These basics make a real difference in how fast you recover: Sleep: Your body's repair machinery runs hardest during deep sleep when GH peaks

"Lasha Talakhadze"

However, in 2006 it became clear that GIP(3-42) does not function as a physiological antagonist in vivo as its maximal circulating levels are insufficient to elicit antagonistic effects ( At the same time, in 2002, Gipr knockout mice were found to be protected against both obesity and insulin resistance induced by high-fat feeding ( Also in 2002, a GIP analogue with an N-terminal substitution of glutamic acid in position 3 with proline (Pro3), was made as an attempt to prolong the GIP actions by protecting from DPP-4 degradation (66) ( Figure 1 )

Supports Balanced Inflammatory Response

PLoS Genet 12:e1005923